ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO755

Impact of Thrice-Weekly In-Centre Nocturnal Hemodialysis on Health-Related Quality of Life

Session Information

Category: Dialysis

  • 601 Standard Hemodialysis for ESRD

Authors

  • Dumaine, Chance Skylar, University of Calgary, Calgary, Alberta, Canada
  • Leung, Kelvin C.W., University of Calgary, Calgary, Alberta, Canada
  • MacRae, Jennifer M., University of Calgary, Calgary, Alberta, Canada
Background

Home hemodialysis is associated with improved health-related quality of life (HRQoL); however, few studies have examined the impact of in-centre nocturnal hemodialysis (ICNHD) on HRQoL or on dialysis-related symptoms. We sought to determine whether conversion from conventional hemodialysis to ICNHD (8 hours, thrice weekly) improves HRQoL or reduces the burden of dialysis-related symptoms.

Methods

Prospective cohort study of conventional in-centre HD patients transitioned to ICNHD between October, 2013, and January, 2016. Health-related quality of life and symptoms associated with dialysis were assessed at baseline using the Kidney Disease Quality of Life-36 (KDQOL-36) survey. Follow-up surveys were completed at 12 months and differences from baseline were assessed using paired t-testing.

Results

Thirty-six patients were enrolled in ICNHD during the study period (69% male, mean age 54). Mean time on dialysis prior to enrollment was 31 months and mean Charlson Comorbidity Index score was 2.19 (range 0-4). Twenty-four patients (67%) were included in final analyses. Table 1 shows changes in the domains of the KDQOL-36. Significant improvements were seen in the “Effects of Kidney Disease” and “Mental Health Composite” domains (increase of 17% and 16%, respectively). Analyses yet to be conducted include an assessment of individual symptoms, as well as a sub-analysis using baseline KDQOL-36 scores to divide the cohort into tertiles.

Conclusion

In-centre nocturnal hemodialysis results in improved HRQoL. Previous studies have shown that patients with the lowest HRQoL at baseline derive the most benefit from home hemodialysis; further analyses will examine whether the same is true for ICNHD. Further studies are needed to determine whether improved HRQoL with ICNHD is associated with improved patient survival.

Table 1: Change in Health-Related Quality of Life
 Baseline
Mean (SD)
12-Month Follow-up
Mean (SD)
p-value
Symptoms/Problems73.4 (11.9)77.0 (12.6)0.09
Effects of Kidney Disease48.2 (23.1)56.4 (22.3)0.046
Burden of Kidney Disease29.7 (25.2)31.8 (23.1)0.33
Physical Health Composite34.7 (7.3)36.4 (10.7)0.24
Mental Health Composite43.9 (12.1)51.0 (10.5)0.003

Table 1: Mean and standard deviations for each of the 5 domains of the KDQOL-36. Each domain scored on a scale of 1 to 100, with higher values representing superior HRQoL.